Skip to main content

Table 6 Drug recovery (%) in ASAQ bilayer tablets after 6 months in various aging conditions.

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

   25°C/60%RH 30°C/65%RH 40°C/75%RH
High dosage tablets AS (%) 100.2 100.7 96.1
  AQ (%) 100.3 102.0 99.6
Low dosage tablets AS (%) 102.0 102.0 99.2
  AQ (%) 101.7 102.7 101.8
  1. Batches 30154C03 and 30154C04 for high and low dosage respectively, DHA < 0,5%